Rachel Aufforth

687 citations
11 papers · 380 indexed · h-index 9
Topics
Cancer, Hypoxia, and Metabolism (4 papers)Adrenal and Paraganglionic Tumors (4 papers)Pituitary Gland Disorders and Treatments (2 papers)

In The Last Decade

Rachel Aufforth

11 papers receiving 379 citations

Peers

Rachel Aufforth
Comparison fields: 5 of 68
  • Surgery 135
  • Biomedical Engineering 117
  • Oncology 113
  • Cancer Research 112
  • Molecular Biology 74
Replace Jonathan C. DeLong with:
Jonathan C. DeLong United States
L. Ley Spain
M Inoue Japan
Song Chen China
Hikaru Nakashima Japan
Yuan Han China
David Fitzpatrick Ireland
Bryant Bonner United States
Ao Li China
Daohu Wang China
Rachel Aufforth relative to Jonathan C. DeLong United States Jonathan C. DeLong's profile →
Citations per field
00.5×3.1×
Jonathan C. DeLong · 1×
Citations per year

Countries citing papers authored by Rachel Aufforth

Since Specialization
Citations

This map shows the geographic impact of Rachel Aufforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Aufforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Aufforth more than expected).

Fields of papers citing papers by Rachel Aufforth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Aufforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Aufforth. The network helps show where Rachel Aufforth may publish in the future.

Co-authorship network of co-authors of Rachel Aufforth

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Aufforth. A scholar is included among the top collaborators of Rachel Aufforth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Aufforth. Rachel Aufforth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 34
2 3
3 21
4 47
5 24
6 32
7 15
8 92
9 71
10 33
11 8

About Rachel Aufforth

Rachel Aufforth is a scholar working on Cancer Research, Genetics and Endocrinology, Diabetes and Metabolism, having authored 11 papers that have together received 380 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Adrenal and Paraganglionic Tumors (4 papers) and Pituitary Gland Disorders and Treatments (2 papers). The work is most often cited by research in Cancer Research (112 citations), Oncology (113 citations) and Anesthesiology and Pain Medicine (23 citations). Rachel Aufforth has collaborated with scholars based in United States, South Korea and Switzerland. Frequent co-authors include Naris Nilubol, Electron Kebebew, Mateusz L. Hupert, Małgorzata A. Witek, Joshua M. Jackson, Jen Jen Yeh, Steven A. Soper, Robert J. Torphy, Joyce W. Kamande and Samira M. Sadowski. Their work appears in journals such as Analytical Chemistry, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026